Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 2
1948 1
1949 1
1952 1
1960 1
1961 2
1963 1
1964 3
1965 2
1966 1
1967 2
1969 2
1970 1
1971 1
1972 3
1973 3
1974 2
1975 9
1976 7
1977 4
1978 6
1979 10
1980 13
1981 1
1982 9
1983 5
1984 11
1985 7
1986 11
1987 7
1988 11
1989 13
1990 10
1991 16
1992 17
1993 18
1994 13
1995 20
1996 23
1997 19
1998 19
1999 12
2000 18
2001 14
2002 18
2003 15
2004 23
2005 22
2006 28
2007 27
2008 21
2009 24
2010 20
2011 25
2012 25
2013 30
2014 27
2015 31
2016 19
2017 20
2018 25
2019 29
2020 16
2021 35
2022 35
2023 28
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

835 results

Results by year

Filters applied: . Clear all
Page 1
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial.
Thieblemont C, Phillips T, Ghesquieres H, Cheah CY, Clausen MR, Cunningham D, Do YR, Feldman T, Gasiorowski R, Jurczak W, Kim TM, Lewis DJ, van der Poel M, Poon ML, Cota Stirner M, Kilavuz N, Chiu C, Chen M, Sacchi M, Elliott B, Ahmadi T, Hutchings M, Lugtenburg PJ. Thieblemont C, et al. Among authors: elliott b. J Clin Oncol. 2023 Apr 20;41(12):2238-2247. doi: 10.1200/JCO.22.01725. Epub 2022 Dec 22. J Clin Oncol. 2023. PMID: 36548927 Free PMC article. Clinical Trial.
Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study.
Hutchings M, Mous R, Clausen MR, Johnson P, Linton KM, Chamuleau MED, Lewis DJ, Sureda Balari A, Cunningham D, Oliveri RS, Elliott B, DeMarco D, Azaryan A, Chiu C, Li T, Chen KM, Ahmadi T, Lugtenburg PJ. Hutchings M, et al. Among authors: elliott b. Lancet. 2021 Sep 25;398(10306):1157-1169. doi: 10.1016/S0140-6736(21)00889-8. Epub 2021 Sep 8. Lancet. 2021. PMID: 34508654 Clinical Trial.
Biomechanics and tennis.
Elliott B. Elliott B. Br J Sports Med. 2006 May;40(5):392-6. doi: 10.1136/bjsm.2005.023150. Br J Sports Med. 2006. PMID: 16632567 Free PMC article. Review.
Colostomy Care: A Guide for Home Care Clinicians.
Berti-Hearn L, Elliott B. Berti-Hearn L, et al. Among authors: elliott b. Home Healthc Now. 2019 Mar/Apr;37(2):68-78. doi: 10.1097/NHH.0000000000000735. Home Healthc Now. 2019. PMID: 30829784 Review.
Ileostomy Care: A Guide for Home Care Clinicians.
Berti-Hearn L, Elliott B. Berti-Hearn L, et al. Among authors: elliott b. Home Healthc Now. 2019 May/Jun;37(3):136-144. doi: 10.1097/NHH.0000000000000776. Home Healthc Now. 2019. PMID: 31058731 Review.
Tennis.
Elliott B, Reid M, Crespo M, Kwon YH. Elliott B, et al. Sports Biomech. 2013 Mar;12(1):1. doi: 10.1080/14763141.2013.772379. Sports Biomech. 2013. PMID: 23724602 No abstract available.
Hairy Tongue.
Karr E, Elliott B. Karr E, et al. Among authors: elliott b. N Engl J Med. 2023 Jul 6;389(1):e3. doi: 10.1056/NEJMicm2300789. N Engl J Med. 2023. PMID: 37407004 No abstract available.
835 results